MaturitasHumansFemaleBreast NeoplasmsEstrogen Receptor betaTamoxifen
Oestrogen receptor beta in breast cancer prognosis and treatment.
Ana Božović, Milica Nedeljković, Bojana Kožik, Lidija Todorović, Milena Krajnović, Snežana Jovanović-Ćupić, Nikola Kokanov, Milan Markićević, Vesna Mandušić
Published: 202510.1016/j.maturitas.2025.108762
Abstract
OBJECTIVES: About 30 % of breast cancer patients do not respond to adjuvant tamoxifen treatment. In addition to classical clinical and pathological parameters, treatment decisions are based on the presence of the oestrogen receptor alfa, the progeste…
Preview only. Read the full abstract at the source